Treatment of Osteoarthritis Using IL-20 Antagonists

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Methods for alleviating or delaying the onset of osteoarthritis in a subject in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20, e.g., an anti-IL-20 antibody.
Original languageEnglish
Patent number9221904
Publication statusPublished - 2014 Jan 23

Fingerprint

Osteoarthritis
Antibodies
interleukin 20

Cite this

@misc{6b7f20ac0a434ab588c8aaab850baf06,
title = "Treatment of Osteoarthritis Using IL-20 Antagonists",
abstract = "Methods for alleviating or delaying the onset of osteoarthritis in a subject in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20, e.g., an anti-IL-20 antibody.",
author = "Ming-Shi Chang",
year = "2014",
month = "1",
day = "23",
language = "English",
type = "Patent",
note = "9221904",

}

TY - PAT

T1 - Treatment of Osteoarthritis Using IL-20 Antagonists

AU - Chang, Ming-Shi

PY - 2014/1/23

Y1 - 2014/1/23

N2 - Methods for alleviating or delaying the onset of osteoarthritis in a subject in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20, e.g., an anti-IL-20 antibody.

AB - Methods for alleviating or delaying the onset of osteoarthritis in a subject in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20, e.g., an anti-IL-20 antibody.

M3 - Patent

M1 - 9221904

ER -